Form 4 for TKR TIMKEN CO
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0000098362-23-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-14 | 2023-02-13 | TKR | Kyle Richard G | Pres, CEO, Dir | S - Sale+OE | $85.27 | -23.1K | 383.1K | -6% | -$1.97M |
| DM | 2023-02-14 | 2023-02-13 | TKR | Kyle Richard G | Pres, CEO, Dir | M - OptEx | $39.48 | +30.0K | 403.1K | +8% | +$1.18M |
| DM | 2023-02-14 | 2023-02-10+ | TKR | Kyle Richard G | Pres, CEO, Dir | F - Tax | $84.34 | -36.3K | 390.2K | -9% | -$3.06M |
| DM | 2023-02-14 | 2023-02-10+ | TKR | Kyle Richard G | Pres, CEO, Dir | A - Grant | $0.00 | +72.6K | 348.2K | +26% | $0 |
| DM | 2023-02-14 | 2023-02-13 | TKR | Kyle Richard G | Pres, CEO, Dir | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 15,973 | $85.23 | 383,082 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $85.07 to $85.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-02-13 | M | A | 10,000 | $27.75 | 393,082 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-10 | F | D | 3,573 | $83.43 | 344,607 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-10 | A | A | 45,898 | $0.00 | 390,505 | D | — | — | (F2) Represents award of shares pursuant to vesting of performance-based restricted share units granted on February 10, 2020. |
| 5 | Common | Common Stock | 2023-02-10 | F | D | 18,661 | $84.41 | 371,844 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-10 | A | A | 5,919 | $0.00 | 377,763 | D | — | — | (F3) Represents vesting of 25% of the time-based restricted share units granted on February 10, 2021. |
| 7 | Common | Common Stock | 2023-02-10 | F | D | 2,537 | $83.43 | 375,226 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-10 | A | A | 7,262 | $0.00 | 382,488 | D | — | — | (F4) Represents vesting of 25% of the time-based restricted share units granted on February 10, 2022. |
| 9 | Common | Common Stock | 2023-02-10 | F | D | 3,112 | $83.43 | 379,376 | D | — | — | |
| 10 | Common | Common Stock | 2023-02-12 | A | A | 5,194 | $0.00 | 384,570 | D | — | — | (F5) Represents vesting of 25% of the time-based restricted share units granted on February 12, 2019. |
| 11 | Common | Common Stock | 2023-02-12 | F | D | 1,488 | $83.43 | 383,082 | D | — | — | |
| 12 | Common | Common Stock | 2023-02-13 | F | D | 4,027 | $85.57 | 399,055 | D | — | — | |
| 13 | Common | Common Stock | 2023-02-13 | M | A | 20,000 | $45.35 | 403,082 | D | — | — | |
| 14 | Common | Common Stock | 2023-02-13 | S | D | 7,105 | $85.35 | 383,082 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $85.28 to $85.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 15 | Common | Common Stock | 2023-02-13 | F | D | 2,895 | $85.57 | 390,187 | D | — | — | |
| 16 | Common | Common Stock | 2023-02-10 | A | A | 8,337 | $0.00 | 348,180 | D | — | — | (F1) Represents vesting of 25% of the time-based restricted share units granted on February 10, 2020. |
| 17 | Derivative | Employee Stock Option (right to buy) | 2023-02-13 | M | D | 20,000 | $0.00 | 0 | D | $45.35 · 2018-02-13 to 2027-02-13 | 20,000 Common Stock | (F9) 20,000 stock options from 2/13/2017 grant of 117,750 stock options (previously reported) that vested in 25% increments per year from the date of grant. |
| 18 | Derivative | Employee Stock Option (right to buy) | 2023-02-13 | M | D | 10,000 | $0.00 | 0 | D | $27.75 · 2017-02-11 to 2026-02-11 | 10,000 Common Stock | (F8) 10,000 stock options from 2/11/2016 grant of 183,800 stock options (previously reported) that vested in 25% increments per year from the date of grant. |